Abstract
Background: Pre-transplant respiratory virus infection has been shown to have negative impact on HCT outcomes even with human rhinoviruses (HRV) alone (Clin Inf Dis 61:192, 2015); however, the sample size was too small to separately analyze HRV and human coronaviruses (HCoV), the two most commonly diagnosed respiratory viruses. This study was performed to revisit this question in a large cohort of HCT recipients who had PCR testing for evaluation of respiratory symptoms before HCT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
